17 HIV AIDS Clinical Trials in Atlanta, GA (2026)

Q: Are there hiv aids clinical trials in Atlanta?

Yes, there are 17 hiv aids clinical trials currently recruiting in Atlanta, GA.

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Q: Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting HIV AIDS Studies in Atlanta

NCT07473778Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the U...

Atlanta, GA3,000 participantsGilead Sciences

View Study Details

NCT07293559Recruiting

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the stud...

Atlanta, GA1,150 participantsInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group

View Study Details

NCT02140255Recruiting

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detecti...

Atlanta, GAPHASE11,120 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT04577313Recruiting

HIV Treatment Adherence Dose Determination Trial

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence....

Atlanta, GANA400 participantsUniversity of Connecticut

View Study Details

NCT06856174Recruiting

Menopausal HT for Women Living With HIV (HoT)

Women living with HIV have been shown to experience more frequent and severe hot flashes and night sweats (collectively known as vasomotor symptoms) as compared to women living without HIV. This corre...

Atlanta, GAPHASE4105 participantsAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

View Study Details

NCT05452564Recruiting

Baricitinib for Reduction of HIV - CNS

There is still no cure for the human immunodeficiency virus (HIV). While combination antiretroviral therapy (cART) is effective in decreasing deaths from HIV, infected individuals face a lifetime of t...

Atlanta, GAPHASE295 participantsWilliam Tyor

View Study Details

NCT05660980Recruiting

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

The purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a long-acting injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children...

Atlanta, GAPHASE190 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT04375800Recruiting

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

This is a single-group, open-label, multi-site study in pediatric participants with human immunodeficiency virus type 1 (HIV-1) infection, aged 4 weeks to \<12 years and weighing \<45 kg, who are trea...

Atlanta, GAPHASE284 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07390955Recruiting

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

This study is testing a lab-made antibody called ePGT121v1-LS that targets a specific part of HIV. Researchers will give it by vein (IV) and under the skin (SC), both on its own and together with two ...

Atlanta, GAPHASE183 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05537935Recruiting

Low Dose Naltrexone for Pain in Patients With HIV

The increased life expectancy of Patients Living With HIV/AIDS (PLWHA) has increased the need for therapies for chronic conditions, such as chronic pain. Pain in the HIV population is often refractory...

Atlanta, GAPHASE460 participantsEmory University

View Study Details

NCT05719441Recruiting

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

A5388 is a phase II, two-arm, randomized, double-blind, placebo-controlled study that will enroll 48 antiretroviral therapy (ART)-naïve adults with acute HIV infection (AHI) in order to determine whet...

Atlanta, GAPHASE248 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06517693Recruiting

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of the potent, broadly neutralizing anti-HIV monoclonal antibodies (mAb) PGT121.414.LS alone and in combination with VRC07...

Atlanta, GAPHASE148 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06796686Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

This is a partially randomized, open-label phase 1 study to evaluate the safety and immunogenicity of a priming regimen of 426c.Mod.Core-C4b adjuvanted with 3M-052 AF + Alum followed by boosts with Hx...

Atlanta, GAPHASE142 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07390474Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

This is a phase 1, multicenter, open-label, dose escalation, first-in-human (FIH) trial to evaluate the safety and immunogenicity of DV201P-RNA and DV202B1-RNA, immunogens designed to induce HIV-1 env...

Atlanta, GAPHASE140 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06071767Recruiting

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

The purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored cons...

Atlanta, GAPHASE136 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05674656Recruiting

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

The purpose of this study is to provide data on the pharmacokinetic (PK), safety, tolerability, efficacy and acceptability of this fixed dose combination (FDC) single tablet 2-drug regimen for virolog...

Atlanta, GAPHASE120 participantsViiV Healthcare

View Study Details

NCT06749054Recruiting

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

The goal of this clinical study is to learn more about the study drug, lenacapavir (LEN). The study will assess the safety, tolerability, and efficacy of long-acting LEN when combined with other medic...

Atlanta, GAPHASE212 participantsGilead Sciences

View Study Details

About HIV AIDS Clinical Trials in Atlanta

HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.

There are currently 17 hiv aids clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 6,433 participants. Research is being sponsored by Gilead Sciences, International Maternal Pediatric Adolescent AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID) and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

HIV AIDS Clinical Trials in Atlanta — FAQ

Are there hiv aids clinical trials in Atlanta?

Yes, there are 17 hiv aids clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What hiv aids treatments are being tested?

The 17 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.

Data updated July 16, 2026 from ClinicalTrials.gov